REG - CVS Group plc - Transaction in Own Shares
Yesterday 07:00
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251201:nRSA5337Ja&default-theme=true
RNS Number : 5337J CVS Group plc 01 December 2025
01 December 2025
CVS GROUP plc
("CVS" or the "Company" and, together with its subsidiaries, the "Group")
Transaction in own shares
CVS announces that on 28 November 2025 it purchased the following number of
its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg,
Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the
terms of the share buyback programme announced on 24 October 2025 (the "Share
Buyback Programme").
Date of purchase: 28/11/2025
Aggregate number of Ordinary Shares purchased: 24,590
Lowest price paid per share (GBp): 1,194.00
Highest price paid per share (GBp): 1,220.00
Volume weighted average price paid per share (GBp): 1,209.33
CVS intends to cancel all of the purchased Ordinary Shares.
Following settlement of the above purchases and cancellation of the Ordinary
Shares purchased, CVS will have 71,062,511 Ordinary Shares in issue and holds
no Ordinary Shares in treasury.
The total number of voting rights in CVS is therefore 71,062,511 and this
figure may be used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their interest in, or
a change to their interest in, CVS under the Financial Conduct Authority's
Disclosure and Transparency Rules.
Since the commencement of the Share Buyback Programme, the Company has
repurchased 678,272 Ordinary Shares in aggregate at a weighted average price
of 1,215.50 pence per share.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation), as it forms part of Retained EU Law as defined in the
European Union (Withdrawal) Act 2018, the table below contains detailed
information of the individual trades made by Berenberg as part of the Share
Buyback Programme.
Individual transactions:
Number of Ordinary Shares purchased Transaction price (GBp share) Time of transaction (UK Time) Transaction reference number Trading Venue
280 1194 28/11/2025 08:08:34 1341568011208953 XLON
73 1194 28/11/2025 08:14:55 1341568011209467 XLON
126 1194 28/11/2025 08:14:55 1341568011209471 XLON
74 1194 28/11/2025 08:22:36 1341568011210075 XLON
226 1200 28/11/2025 09:00:00 1341568011212777 XLON
90 1198 28/11/2025 09:00:29 1341568011212799 XLON
670 1198 28/11/2025 09:00:29 1341568011212800 XLON
73 1198 28/11/2025 09:00:51 1341568011212813 XLON
73 1198 28/11/2025 09:03:00 1341568011212966 XLON
73 1202 28/11/2025 09:09:53 1341568011213305 XLON
1168 1200 28/11/2025 09:15:31 1341568011213736 XLON
73 1200 28/11/2025 09:17:35 1341568011213849 XLON
959 1198 28/11/2025 09:22:18 1341568011214055 XLON
316 1198 28/11/2025 09:22:18 1341568011214057 XLON
97 1200 28/11/2025 09:38:13 1341568011214785 XLON
149 1200 28/11/2025 09:38:13 1341568011214786 XLON
692 1204 28/11/2025 10:08:49 1341568011216739 XLON
100 1204 28/11/2025 10:08:49 1341568011216741 XLON
232 1200 28/11/2025 10:09:00 1341568011216754 XLON
94 1196 28/11/2025 11:02:42 1341568011219419 XLON
236 1196 28/11/2025 11:02:42 1341568011219421 XLON
25 1196 28/11/2025 11:02:42 1341568011219422 XLON
20 1194 28/11/2025 11:39:49 1341568011221118 XLON
6 1194 28/11/2025 11:39:49 1341568011221119 XLON
48 1194 28/11/2025 11:39:49 1341568011221120 XLON
9 1194 28/11/2025 11:42:27 1341568011221210 XLON
3 1194 28/11/2025 11:42:27 1341568011221211 XLON
3 1194 28/11/2025 11:42:27 1341568011221212 XLON
58 1194 28/11/2025 11:42:27 1341568011221213 XLON
73 1196 28/11/2025 11:46:00 1341568011221378 XLON
6 1202 28/11/2025 13:07:46 1341568011225614 XLON
6 1202 28/11/2025 13:07:46 1341568011225615 XLON
381 1204 28/11/2025 13:27:07 1341568011226834 XLON
1012 1204 28/11/2025 13:27:07 1341568011226835 XLON
1302 1204 28/11/2025 13:29:00 1341568011226867 XLON
279 1204 28/11/2025 13:29:00 1341568011226869 XLON
240 1202 28/11/2025 13:30:01 1341568011227032 XLON
851 1202 28/11/2025 13:30:01 1341568011227033 XLON
479 1204 28/11/2025 14:03:41 1341568011229406 XLON
49 1208 28/11/2025 14:25:27 1341568011231420 XLON
130 1210 28/11/2025 14:32:03 1341568011232561 XLON
171 1210 28/11/2025 14:33:00 1341568011232739 XLON
69 1210 28/11/2025 14:34:27 1341568011233039 XLON
20 1210 28/11/2025 14:34:27 1341568011233040 XLON
20 1210 28/11/2025 14:34:27 1341568011233045 XLON
559 1210 28/11/2025 14:34:27 1341568011233044 XLON
82 1210 28/11/2025 14:34:27 1341568011233041 XLON
82 1210 28/11/2025 14:34:27 1341568011233046 XLON
89 1210 28/11/2025 14:34:27 1341568011233047 XLON
718 1210 28/11/2025 14:34:27 1341568011233048 XLON
88 1210 28/11/2025 14:34:33 1341568011233065 XLON
83 1210 28/11/2025 14:34:33 1341568011233066 XLON
116 1210 28/11/2025 14:34:37 1341568011233073 XLON
55 1210 28/11/2025 14:36:25 1341568011233337 XLON
6 1210 28/11/2025 14:49:04 1341568011235615 XLON
7 1210 28/11/2025 14:49:04 1341568011235616 XLON
3 1210 28/11/2025 14:49:04 1341568011235617 XLON
155 1210 28/11/2025 14:52:51 1341568011236159 XLON
171 1210 28/11/2025 14:52:51 1341568011236167 XLON
10 1210 28/11/2025 14:52:51 1341568011236168 XLON
46 1214 28/11/2025 15:12:18 1341568011239587 XLON
7 1214 28/11/2025 15:12:18 1341568011239588 XLON
313 1214 28/11/2025 15:12:18 1341568011239589 XLON
1 1214 28/11/2025 15:16:47 1341568011240190 XLON
71 1214 28/11/2025 15:17:19 1341568011240284 XLON
171 1214 28/11/2025 15:20:02 1341568011240564 XLON
11 1214 28/11/2025 15:20:02 1341568011240565 XLON
160 1214 28/11/2025 15:20:02 1341568011240566 XLON
11 1214 28/11/2025 15:20:02 1341568011240567 XLON
171 1214 28/11/2025 15:20:02 1341568011240568 XLON
171 1214 28/11/2025 15:20:02 1341568011240569 XLON
171 1214 28/11/2025 15:20:02 1341568011240570 XLON
171 1214 28/11/2025 15:20:02 1341568011240571 XLON
171 1214 28/11/2025 15:20:02 1341568011240572 XLON
171 1214 28/11/2025 15:20:02 1341568011240573 XLON
171 1214 28/11/2025 15:20:02 1341568011240574 XLON
160 1214 28/11/2025 15:20:02 1341568011240575 XLON
11 1214 28/11/2025 15:20:02 1341568011240576 XLON
160 1214 28/11/2025 15:20:02 1341568011240577 XLON
171 1214 28/11/2025 15:20:02 1341568011240578 XLON
171 1214 28/11/2025 15:20:02 1341568011240579 XLON
171 1214 28/11/2025 15:20:02 1341568011240580 XLON
171 1214 28/11/2025 15:20:02 1341568011240581 XLON
11 1214 28/11/2025 15:20:02 1341568011240582 XLON
160 1214 28/11/2025 15:20:02 1341568011240583 XLON
11 1214 28/11/2025 15:20:02 1341568011240584 XLON
171 1214 28/11/2025 15:20:02 1341568011240585 XLON
171 1214 28/11/2025 15:20:02 1341568011240586 XLON
171 1214 28/11/2025 15:20:02 1341568011240587 XLON
88 1214 28/11/2025 15:20:02 1341568011240588 XLON
83 1214 28/11/2025 15:20:02 1341568011240589 XLON
171 1214 28/11/2025 15:20:02 1341568011240590 XLON
171 1214 28/11/2025 15:21:39 1341568011241048 XLON
689 1214 28/11/2025 15:21:39 1341568011241050 XLON
282 1214 28/11/2025 15:21:39 1341568011241052 XLON
631 1220 28/11/2025 15:34:20 1341568011243277 XLON
479 1220 28/11/2025 15:34:37 1341568011243389 XLON
376 1220 28/11/2025 15:34:37 1341568011243395 XLON
108 1220 28/11/2025 15:41:17 1341568011244813 XLON
139 1220 28/11/2025 15:41:17 1341568011244814 XLON
32 1220 28/11/2025 15:41:17 1341568011244815 XLON
171 1220 28/11/2025 15:41:17 1341568011244816 XLON
171 1220 28/11/2025 15:41:18 1341568011244818 XLON
171 1220 28/11/2025 15:41:20 1341568011244824 XLON
85 1220 28/11/2025 15:41:20 1341568011244825 XLON
171 1220 28/11/2025 15:41:25 1341568011244843 XLON
298 1220 28/11/2025 15:41:25 1341568011244846 XLON
171 1220 28/11/2025 15:41:30 1341568011244851 XLON
2415 1220 28/11/2025 15:41:30 1341568011244855 XLON
171 1220 28/11/2025 15:50:30 1341568011246421 XLON
135 1220 28/11/2025 15:50:30 1341568011246425 XLON
36 1220 28/11/2025 15:50:30 1341568011246426 XLON
26 1220 28/11/2025 15:50:30 1341568011246428 XLON
171 1220 28/11/2025 15:50:30 1341568011246429 XLON
93 1220 28/11/2025 15:50:30 1341568011246430 XLON
Contacts
CVS Group
plc
via Camarco
Richard Fairman, CEO
Robin Alfonso, CFO
Paul Higgs, Chief Veterinary Officer
Charlotte Page, Head of Investor Relations
Peel Hunt LLP (Nominated Adviser & Joint Broker)
+44 (0)20 7418 8900
Christopher Golden / James Steel / Andrew Clark
Berenberg (Joint
Broker)
+44 (0)20 3207 7800
Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing
Camarco (Financial PR)
cvsg@camarco.co.uk
Ginny Pulbrook
+44 (0)7961
315 138
Letaba Rimell
Tilly Butcher
About CVS Group plc (www.cvsukltd.co.uk)
CVS Group is an AIM-listed provider of veterinary services with operations in
the UK and Australia. CVS is focused on providing high-quality clinical
services to its clients and their animals, with outstanding and dedicated
clinical teams and support colleagues at the core of its strategy.
The Group now operates c.470 veterinary practices across its two territories,
including specialist referral hospitals and dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third-parties) and an online retail
business ("Animed Direct").
The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and
c.3,300 nurses.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSPPGPCGUPAGRR
Copyright 2019 Regulatory News Service, all rights reservedRecent news on CVS
See all newsREG - CVS Group plc - Transaction in Own Shares
AnnouncementREG - CVS Group plc - SAYE Option Scheme & PDMR Dealing
AnnouncementREG - CVS Group plc - Total Voting Rights
AnnouncementREG - CVS Group plc - Transaction in Own Shares
AnnouncementREG - CVS Group plc - Transaction in Own Shares
Announcement